LOCAL ANESTHETIC FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS RESULTING FROM BRAIN DYSFUNCTIONS
申请人:ICM (Institut du Cerveau et de la Moelle Épinière)
公开号:EP3914246A1
公开(公告)日:2021-12-01
US3988473A
申请人:——
公开号:US3988473A
公开(公告)日:1976-10-26
[EN] LOCAL ANESTHETIC FOR THE TREATMENT OF NEUROLOGICAL SYMPTOMS RESULTING FROM BRAIN DYSFUNCTIONS<br/>[FR] ANESTHÉSIQUE LOCAL POUR LE TRAITEMENT DE SYMPTÔMES NEUROLOGIQUES RÉSULTANT DE DYSFONCTIONNEMENTS CÉRÉBRAUX
申请人:ICM INST DU CERVEAU ET DE LA MOELLE EPINIERE
公开号:WO2020152212A1
公开(公告)日:2020-07-30
The present invention relates to a local anesthetic from the group consisting of amino amide or amino ester for use in the treatment of neurological symptoms resulting from brain dysfunctions such as motor, cognitive, sensory, visual deficits, and/or apathetic, catatonic, vegetative and/or minimally conscious states.
Tertiary-alkylamino-lower acyl-xylidide local anaesthetics
申请人:Astra Pharmaceutical Products, Inc.
公开号:US03988473A1
公开(公告)日:1976-10-26
Tertiary-alkylamino-lower acyl-xylidides have unusually long lasting local anaesthetic effect or high local anaesthetic activity while also having a satisfactory low level of tissue irritation and a satisfactory low acute toxicity. Combinations of such local anaesthetics with the biotoxins tetrodotoxin or saxitoxin are disclosed. Novel tertiary alkyl secondary amines, and methods for preparing such local anaesthetics and amines are also disclosed.